Use of Allograft Adipose Matrix for Small Joint Arthritis of the Hand
Status:
Not yet recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
The purpose the research is to evaluate the safety and efficacy of injection of adipose
allograft matrix (AAM) to the small joints of the hand for treatment of early stage
osteoarthritis. The hypothesis is that use of AAM injected directly into the joint will show
improvements in pain and disability while providing a safe, off-the-shelf alternative which
can obviate the need for, and risks associated with, current treatment options with
autologous fat transfer.
As standard of care, routine strength, pain scale scores (VAS) and range of motion will be
recorded, a baseline disability survey (DASH score) will also be administered. After these
have all been recorded and administered in a separate visit the patient will undergo the
lipofilling procedure.
The subject population will include patients over the age of 18 who present with joint pain
of the hand with radiographic evidence of osteoarthritis.